Protagenic Therapeutics, Inc.\new Proceeds from Stock Options Exercised
Protagenic Therapeutics, Inc.\new (PTIX) reported Proceeds from Stock Options Exercised of $542.50 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2022-11-14
- Protagenic Therapeutics, Inc.\new proceeds from stock options exercised for the quarter ending 2021-09-30 was $0.00.
- Protagenic Therapeutics, Inc.\new proceeds from stock options exercised for the quarter ending 2021-06-30 was $532.50K.
- Protagenic Therapeutics, Inc.\new proceeds from stock options exercised for the quarter ending 2011-09-30 was -$1.00K.
- Protagenic Therapeutics, Inc.\new proceeds from stock options exercised for fiscal 2016 was $6.50K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $532.50K derived: sum of 2 quarters · filed 2022-11-14 | $542.50K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $532.50K 10-K · filed 2022-04-07 | $542.50K 10-Q · filed 2022-08-11 | ||
| 2016-12-31 | $6.50K 10-K · filed 2018-04-02 | |||
| 2011-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | $90.00K 10-Q · filed 2011-11-14 | ||
| 2011-06-30 | $91.00K 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |